StockNews.com initiated coverage on shares of Athersys (NASDAQ:ATHX – Get Free Report) in a research report issued on Sunday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock.
Athersys Stock Performance
The company has a market capitalization of $833,000.00, a price-to-earnings ratio of -0.01 and a beta of -0.90. Athersys has a 52 week low of $0.01 and a 52 week high of $1.99.
Athersys Company Profile
Featured Articles
- Five stocks we like better than Athersys
- What is the Euro STOXX 50 Index?
- Moderna Dips on Q2 Earnings But Can It Rip on a Short Squeeze?
- What is the Hang Seng index?
- 2 Option Strategies to Maximize Profits in a Bear Market
- What is the Australian Securities Exchange (ASX)
- Lululemon Stock Gears Up for a Massive Comeback Rally
Receive News & Ratings for Athersys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Athersys and related companies with MarketBeat.com's FREE daily email newsletter.